Back to Search
Tri-Estarylla
by Xiromed, LLC.ContraceptionCOCP
Actively PrescribedGeneric

Estrogen

Ethinyl Estradiol

0.035Mg,0.035Mg,0.035Mg

Progestin

Norgestimate

0.18Mg,0.215Mg,0.25Mg

Regimen Protocol

Triphasic 28 day

Androgenicity

Low/Reduced Androgenic

Approval Date

1/30/2013

Additives
None
Inactive Ingredients
lactose anhydrouspregelatinized starchcrospovidoneD &C Yellow No.10 Aluminum LakeFD & C Blue No.2 lakemagnesium stearate

Contains common allergens

Active Alternative Brands
Alternative brands with the same formulation that are actively prescribed

Glenmark Pharmaceuticals Ltd

Norgestimate And Ethinyl Estradiol

Lupin Ltd

Norgestimate And Ethinyl Estradiol

Naari Pte Ltd

Norgestimate And Ethinyl Estradiol

Northstar Rx LLC

Tri-Linyah

Aurobindo Pharma Limited

Tri-Mili

Teva Pharmaceuticals USA, Inc.

Tri-Sprintec

Have clinical questions about Tri-Estarylla?

Get evidence-based, cited answers from our AI co-pilot for hormone health.

Try Dama Assist

© 2026 Dama Health. All rights reserved.

This tool is intended for use by licensed healthcare professionals. It provides reference information on FDA-approved contraception and hormone therapy products. Results should not be used as a substitute for clinical judgment. Data is sourced from the FDA Orange Book and other FDA-sourced resources and may contain errors or omissions.

Last updated: July 2025 | Powered by Dama Health | Terms of Use | Privacy Policy